Hyderabad Telangana, India

Konduri Srinivasa Krishna Murthy

This inventor holds 1 USPTO granted patent. Top assignee: Natco Pharma Limited. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Konduri Srinivasa Krishna Murthy. Retrieved from https://idiyas.com/inventor/konduri-srinivasa-krishna-murthy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Konduri Srinivasa Krishna Murthy: Innovator in Pharmaceutical Chemistry

Introduction

Konduri Srinivasa Krishna Murthy, based in Hyderabad, Telangana, India, is a notable inventor in the field of pharmaceutical chemistry. He has made significant contributions through his innovative approach to drug formulation, particularly in the development of Sugammadex sodium. His work reflects a commitment to improving pharmaceutical processes and ensuring higher purity in medicinal compounds.

Latest Patents

Konduri has been awarded a patent for his invention titled "Process for the preparation of Sugammadex sodium and its novel polymorphic form." This patent outlines an improved method for the synthesis of Sugammadex sodium, achieving over 98.5% purity while minimizing impurities. The process effectively reduces the levels of monohydroxy Sugammadex sodium to less than 1.0% and any other known or unknown impurities to less than 0.15%, as determined by High-Performance Liquid Chromatography (HPLC). This advancement has significant implications for the pharmaceutical industry, enhancing the quality and efficacy of anesthetic drugs.

Career Highlights

Konduri currently works at Natco Pharma Limited, a leading pharmaceutical company where he utilizes his expertise to drive innovation in drug development. His experience and knowledge in pharmaceutical sciences have been instrumental in advancing the company's research initiatives.

Collaborations

Throughout his career, Konduri has collaborated with colleagues such as Vanga Prabhakar and Baddula Saidulu, both of whom share a commitment to advancing pharmaceutical technologies. Their teamwork has fostered an environment of creativity and innovation, leading to breakthroughs in drug formulation and production processes.

Conclusion

Konduri Srinivasa Krishna Murthy exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly through his patent for Sugammadex sodium, showcase his dedication to developing processes that enhance drug purity and effectiveness. As a vital member of Natco Pharma Limited, Konduri continues to influence the field of pharmaceuticals positively, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…